Tempest Therapeutics (TPST)

• Market cap: $11.6M
• 1 day: 2.16%
• 5 days: -2.07%
• 1 month: -13.55%
• 3 months: -73.36%
• 6 months: -74.73%
• Year to date: -20%
• 1 year: -80.53%
• 5 years: -99.56%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Employees: 5